
Simon Lewin Adherence to TB Medication PLoS Med 4(7):e238. doi:10.1371/journal.pmed.0040238 SIMON LEWIN, London School of Hygiene and Tropical Medicine A new systematic review has shown that we don

Paul Fisher REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles PAUL FISHER, Columbia University, New York Patients with cancer could soon be treated with adenoviruses capable of infecting b

Ludwig Kappos REFERENCE: Lancet 2007; 370: 389-97 LUDWIG KAPPOS, University Hospital, Basel Earlier treatment can reduce the risk of confirmed disability in patients with multiple sclerosis, according



&ot

Simon Lewin REFERENCE: PLoS Med 4(7):e238. doi:10.1371/journal.pmed.0040238 SIMON LEWIN, London School of Hygiene and Tropical Medicine Non-adherence is a big factor reducing the efficacy of tuberculo

&t Margaret Johnson ;em>REFERENCE: Lancet 2007; 370:39-48 MARGARET JOHNSON, Royal Free Hospital, London A new non-nucleoside reverse-transcriptase inhibitor has demonstrated its activity in patie

Rengaswamy Sankaranarayanan REFERENCE: Lancet 2007;370:398-406 RENGASWAMY SANKARANARAYANAN, International Agency for Research on Cancer, Lyon An inexpensive visual cervix cancer-screening test has pro

&ot&uot Kate Stern REFERENCE: O-144 KATE STERN, Royal Women’s Hospital, Melbourne A potential new way of preserving ovarian function during chemotherapy for cancer could be treatment w

Mitchell Shiffman REFERENCE: N Engl J Med 2007;357:124-34 MITCHELL SHIFFMAN, Virginia Commonwealth University, Richmond Standard anti-viral therapy for Hepatitis C needs to be used to the full duratio